Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
West Pharmaceutical ServicesWST +0.58%95 Days Sales Outstanding is 73.10 as of Jun. 2026, which is 22% above its 10-year median of 60.08. GuruFocus rates WST with a GF Scoreâ„¢ of 95/100 and a GF Valueâ„¢ of $357.81 (Fairly Valued). The stock has 9 warning signs investors should review. Among 811 Medical Devices & Instruments companies, West Pharmaceutical Services ranks worse than 54.87% on this metric.
The historical rank and industry rank for West Pharmaceutical Services's Days Sales Outstanding or its related term are showing as below:
WST'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 46.18 Med: 60.08 Max: 69.77
Current: 69.77
During the past 13 years, West Pharmaceutical Services's highest Days Sales Outstanding was 69.77. The lowest was 46.18. And the median was 60.08.
WST's Days Sales Outstanding is ranked worse than 54.87% of 811
companies
in the Medical Devices & Instruments industry
Industry Median: 65.38
vs WST: 69.77
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
West Pharmaceutical Services Days Sales Outstanding Chart
WST vs MDLN, SOLV, COO: Days Sales Outstanding Comparison
For the Medical Instruments & Supplies subindustry, West Pharmaceutical Services's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
West Pharmaceutical Services Days Sales Outstanding vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, West Pharmaceutical Services's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where West Pharmaceutical Services's Days Sales Outstanding falls into.
West Pharmaceutical Services Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
West Pharmaceutical Services (WST) has a Days Sales Outstanding of 73.10 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on West Pharmaceutical Services and its competitors. This is 22% above median its historical median of 60.08. Over the past decade, West Pharmaceutical Services' Days Sales Outstanding has ranged from 46.18 to 69.77. According to the industry distribution chart, West Pharmaceutical Services ranks #445 out of 811 companies in the Medical Devices & Instruments industry, placing it in the top 54.9%.
Is West Pharmaceutical Services' Days Sales Outstanding too high?
West Pharmaceutical Services' current Days Sales Outstanding of 73.10 is 22% above median its 10-year median of 60.08. Over the past 10 years, this metric has ranged from a low of 46.18 to a high of 69.77. The Medical Devices & Instruments industry median Days Sales Outstanding is 65.38. West Pharmaceutical Services' value of 73.10 is 11.8% above this industry median. Based on the distribution chart, West Pharmaceutical Services ranks #445 out of 811 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, West Pharmaceutical Services has a GF Scoreâ„¢ of 95/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does West Pharmaceutical Services' Days Sales Outstanding compare to MDLN and SOLV?
According to the Medical Devices & Instruments industry distribution chart, West Pharmaceutical Services ranks #445 out of 811 companies for Days Sales Outstanding. This places West Pharmaceutical Services in the lower half of its industry. The industry median Days Sales Outstanding is 65.38. West Pharmaceutical Services' value of 73.10 is 11.8% above this benchmark. Historically, West Pharmaceutical Services' own Days Sales Outstanding has ranged from 46.18 to 69.77 over the past decade. While the company's 10-year median is 60.08 vs. the industry median of 65.38, West Pharmaceutical Services has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Devices & Instruments company?
The median Days Sales Outstanding among Medical Devices & Instruments companies is 65.38, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. West Pharmaceutical Services's current Days Sales Outstanding of 73.10 is 11.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on West Pharmaceutical Services and its competitors. For the Medical Devices & Instruments industry, the median Days Sales Outstanding is 65.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. West Pharmaceutical Services's current Days Sales Outstanding is 73.10, which is 22% above median its own 10-year median of 60.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is West Pharmaceutical Services stock overvalued right now?
Based on GuruFocus' analysis, West Pharmaceutical Services (WST) is currently considered Fairly Valued. The stock's GF Value™ is $357.81, compared to a current price of $346.23 — trading 3.2% below its estimated fair value. The current Days Sales Outstanding is 73.10, which is 22% above median its 10-year median of 60.08 and 11.8% above the Medical Devices & Instruments industry median of 65.38. West Pharmaceutical Services' overall GF Score™ is 95/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For West Pharmaceutical Services (WST), the current Days Sales Outstanding is 73.10 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is West Pharmaceutical Services (WST) Overvalued in 2026?
Based on GuruFocus' analysis, West Pharmaceutical Services stock appears to be undervalued.
The current stock price of $346.23 is trading 3.2% below its estimated GF Value™ of $357.81.
GuruFocus considers West Pharmaceutical Services to be Fairly Valued.
Key valuation signals for WST:
Days Sales Outstanding: 73.10 (22% above median its 10-year median of 60.08)
GF Value™: $357.81 vs. price of $346.23 (3.2% below fair value)
Industry Position: 11.8% above the Medical Devices & Instruments median (#445 of 811)
No single metric tells the full story. See the WST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
95GF Score
Get the complete analysis for WST
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WST has been successfully added to your 
